No Data
No Data
No Data
No Data
No Data
YS Biopharma Reports 9M Results
Seeking AlphaApr 19 17:35 ET
Earnings Call Summary | YS Biopharma(YS.US) Q3 2024 Earnings Conference
The following is a summary of the YS Biopharma Co., Ltd. (YS) Q3 2024 Earnings Call Transcript:Financial Performance:YS Biopharma reported a total revenue of RMB 438.1 million for the first nine month
moomoo AIApr 19 09:16 ET · Conference Call
Express News | YS Biopharma Co 9M 2024 EPS Loss Of RMB (1.04) Versus RMB (2.71) YoY
Moomoo 24/7Apr 19 07:13 ET
Express News | YS Biopharma Co 9M 2024 Sales Of $61.9M
Moomoo 24/7Apr 19 07:12 ET
Press Release: YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024
Dr. David Shao continued, "At the corporate level, since late 2023 we have embarked on a comprehensive series of initiatives aimed at fortifying our foundation for future growth.
Dow JonesApr 19 07:00 ET
YS Biopharma Granted Phase I Clinical Trial License Of Therapeutic Chronic Hepatitis B Virus Vaccine
YS Biopharma Co., Ltd. (NASDAQ:YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines
BenzingaApr 18 08:11 ET
dSuu : gonna run back up ya think in market?
TrytosaveabitOP dSuu: Got to wait and see? Anytime this even sees a small increase, shorts jump hard! They love to attack especially China tickers!
dSuu TrytosaveabitOP: thx gl today
TrytosaveabitOP dSuu: You’re welcome! Ty and GL to you
No Data
No Data
seb240sx :
眼见比实力重要 :